The National Cancer Institute is offering a grant to integrate cognitive neuroscience approaches to enhance the assessment of cognitive changes post-cancer treatment, focusing on non-central nervous system malignancies. This grant aims to improve traditional evaluation methods for acute and chronic cognitive impairments. Closing date: June 8, 2022.
Opportunity ID: 319429
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-19-339 |
| Funding Opportunity Title: | Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.395 — Cancer Treatment Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 12, 2019 |
| Last Updated Date: | Aug 12, 2019 |
| Original Closing Date for Applications: | Jun 08, 2022 |
| Current Closing Date for Applications: | Jun 08, 2022 |
| Archive Date: | Jul 14, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Private institutions of higher education For profit organizations other than small businesses Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education State governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Independent school districts Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments City or township governments Special district governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This FOA encourages the integration of cognitive neuroscience approaches to improve traditional assessment of acute and chronic cognitive changes following cancer treatment for non-central nervous system malignancies. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-19-339.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 319429 Full Announcement-PAR-19-339 -> PAR-19-339-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00253803 | Sep 09, 2019 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00259776 | Sep 09, 2019 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00270264 | Nov 16, 2021 | Jun 08, 2022 | View |
Package 1
Mandatory forms
319429 RR_SF424_2_0-2.0.pdf
319429 PHS398_CoverPageSupplement_4_0-4.0.pdf
319429 RR_OtherProjectInfo_1_4-1.4.pdf
319429 PerformanceSite_2_0-2.0.pdf
319429 RR_KeyPersonExpanded_2_0-2.0.pdf
319429 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
319429 RR_Budget_1_4-1.4.pdf
319429 RR_SubawardBudget30_1_4-1.4.pdf
319429 PHS398_ModularBudget_1_2-1.2.pdf
319429 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
319429 RR_SF424_2_0-2.0.pdf
319429 PHS398_CoverPageSupplement_5_0-5.0.pdf
319429 RR_OtherProjectInfo_1_4-1.4.pdf
319429 PerformanceSite_2_0-2.0.pdf
319429 RR_KeyPersonExpanded_2_0-2.0.pdf
319429 PHS398_ResearchPlan_4_0-4.0.pdf
319429 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
319429 RR_Budget_1_4-1.4.pdf
319429 RR_SubawardBudget30_1_4-1.4.pdf
319429 PHS398_ModularBudget_1_2-1.2.pdf
319429 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
319429 RR_SF424_5_0-5.0.pdf
319429 PHS398_CoverPageSupplement_5_0-5.0.pdf
319429 RR_OtherProjectInfo_1_4-1.4.pdf
319429 PerformanceSite_4_0-4.0.pdf
319429 RR_KeyPersonExpanded_4_0-4.0.pdf
319429 PHS398_ResearchPlan_4_0-4.0.pdf
319429 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
319429 RR_Budget_3_0-3.0.pdf
319429 RR_SubawardBudget30_3_0-3.0.pdf
319429 PHS398_ModularBudget_1_2-1.2.pdf
319429 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
